Controlling medicines in Europe: the harmonisation of regulatory toxicology assessed

摘要

EU regulations over the last two decades have raised important questions about the possible Europeanisation of toxicology. For the most part Europeanisation of regulatory toxicology has concentrated on streamlining toxicological testing for efficiency purposes, rather than having the primary goal of raising safety standards, because efficiency is the key priority for the dominant industrial interests. Consumer organisations have been insufficiently consulted and there is little openness about toxicology results. European harmonisation should put more emphasis on accountability to non-industrial interests.